Estimations des analystes de Wall Street pour AC Immune S.A. (ACIU): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 8 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 9 |
| Note moyenne (1-5) | 0.89 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-03 | $-0.22 | ||
| 2026-08-05 | $0.03 | $-0.10 | +128.7% |
| 2026-04-30 | $-0.19 | $-0.20 | +5.0% |
| 2026-03-13 | $-0.18 | $-0.19 | +5.3% |
| 2025-11-04 | $-0.20 | $-0.22 | +9.1% |
| 2025-08-05 | $-0.25 | $-0.20 | -25.0% |
| 2025-04-30 | $-0.21 | $-0.22 | +4.5% |
| 2025-03-13 | $-0.18 | $-0.21 | +14.3% |
Ratios de valorisation
| Prix / Valeur comptable | 6.42 |
| EV / EBITDA | -5.05 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $23.2M | $20.3M | $7.2M | $110.5M | $15.4M | 0 | $3.9M | $14.8M | $27.3M | $3.6M |
| Coût des Ventes | $25.8M | $32.7M | $44.3M | $50.4M | $59.5M | 0 | 0 | $54.6M | $62.6M | 0 |
| Marge Brute | -$2.6M | -$12.4M | -$37.1M | $60.0M | -$44.1M | 0 | $3.9M | -$39.8M | -$35.3M | $3.6M |
| R&D | $25.8M | $32.7M | $44.3M | $50.4M | $59.5M | $62.3M | $60.3M | $54.6M | $62.6M | $56.4M |
| Frais Généraux | $4.7M | $6.3M | $7.6M | $16.1M | $18.6M | $10.9M | $9.6M | $10.6M | $11.4M | $11.7M |
| Charges Opérationnelles | $33.7M | $42.8M | $56.7M | $15.5M | $17.2M | $79.0M | $74.8M | $13.8M | $17.1M | $72.4M |
| Résultat Opérationnel | -$10.5M | -$22.5M | -$49.5M | $44.5M | -$61.3M | -$79.0M | -$70.8M | -$53.6M | -$52.4M | -$68.9M |
| EBITDA | -$6.8M | -$22.5M | -$49.7M | $45.8M | -$59.7M | -$70.0M | -$68.0M | -$51.8M | -$48.6M | -$67.8M |
| Charges d'Intérêt | $256000 | $147000 | $334000 | $1.9M | $184000 | $581000 | $355000 | $176000 | $133000 | $191000 |
| Résultat Avant Impôts | -$7.1M | -$26.4M | -$51.0M | $45.4M | -$61.9M | -$73.0M | -$70.7M | -$54.2M | -$50.9M | -$70.4M |
| Impôts | 0 | $147000 | 0 | 0 | 0 | $3000 | $13000 | $10000 | $3000 | 0 |
| Résultat Net | -$7.1M | -$26.4M | -$51.0M | $45.4M | -$61.9M | -$73.0M | -$70.8M | -$54.2M | -$50.9M | -$70.4M |
| BPA | $-0.14 | $-0.46 | $-0.82 | $0.64 | $-0.86 | $-0.97 | $-0.85 | $-0.64 | $-0.51 | $-0.70 |
| BPA Dilué | $-0.14 | $-0.46 | $-0.82 | $0.64 | $-0.86 | $-0.97 | $-0.85 | $-0.64 | $-0.51 | $-0.70 |
| Actions en Circulation (Diluées) | $50.1M | $57.4M | $61.8M | $71.1M | $71.9M | $75.0M | $83.6M | $84.7M | $99.7M | $100.8M |
Prix
| Prix | $2.65 |
| Capitalisation | $270M |
| Bourse | NASDAQ |
| Pays | CH |
Entreprises liées: ALDX · AMRN · ANNX · ANRO · CLLS · CTNM · DRTS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACIU: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions